Takeda Pharmaceutical Company Stock
Takeda Pharmaceutical Company Limited
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Japan
- CEO
- Julie So-Young Kim
- Employees
- 47,029
- Market cap
- $62.6 B
- IPO
- 05/01/2010
Takeda Pharmaceutical Company Limited is a prominent global biopharmaceutical entity dedicated to the discovery, development, manufacturing, commercialization, and out-licensing of pharmaceutical products. Headquartered in Tokyo, Japan, the company was founded in 1781. Its operations extend across a vast international…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Takeda Pharmaceutical Company stock: price history
1D
+1.1%
1W
+5.0%
1M
+5.5%
6M
+10.4%
YTD
+26.2%
1Y
+41.7%
2Y
+39.7%
5Y
+39.5%
10Y
-15.5%
Next earnings date
Next earnings date
29/10/2026 (in 12 days)
Volatility around earnings
~2% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 15/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Takeda Pharmaceutical Company stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.
Takeda Pharmaceutical Company Limited is a globally operating biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of pharmaceuticals. The portfolio is focused on highly specialized therapeutic areas such as gastroenterology, immunology, rare diseases, oncology, and neurosciences. Business operations encompass the sale of patent-protected medicines under various brand names as well as strategic in-licensing and out-licensing activities to promote innovation. Geographically, the business is distributed across global markets, with the United States being the largest revenue contributor. The model is substantially based on intellectual property protection and continuous research in complex medical fields.
- Revenue model
- Transactional
- Recurring revenue
- High
- Pricing power
- Strong
- Moat
- Wide
- Moat type
- Network effects
- Capital intensity
- High
- Customer concentration
- Unknown
Suppliers & customers in our universe
Exelixis, Inc.Description
Neurocrine Biosciences, Inc.Description
Arrowhead Pharmaceuticals, Inc.Description
Ovid Therapeutics Inc.DescriptionAsk the agents about Takeda Pharmaceutical Company
Analyst assessment of Takeda Pharmaceutical Company
0
STRONG BUY
5
BUY
1
HOLD
0
SELL
0
STRONG SELL
6
TOTAL · Buy
As of: 16/05/2023
Takeda Pharmaceutical Company stock metrics
P/E
54.48
P/B
1.29
EV/EBITDA
11.16
RETURN ON EQUITY
1.5%
NET MARGIN
9.3%
DEBT/EQUITY
0.65
DIVIDEND YIELD
3.2%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.2%
FLOAT SHARES
3,156,801,398
AVG. DAILY VOLUME (30D)
2,595,718
Insider transactions (SEC)
Duprey Lauren Rusckowski
Plump Andrew Stewart
Plump Andrew Stewart
Greenway Nicola Deidre Petal
Farajallah Awny Samaan Botros
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: +1.1%
Forums (Reddit)
Institutional holders
Dividends
Comparable stocks
Frequently asked questions about Takeda Pharmaceutical Company stock
What does Takeda Pharmaceutical Company do?
Takeda Pharmaceutical Company Limited is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Japan.
The CEO is Julie So-Young Kim, the company employs around 47,029 people.
The IPO was on 05/01/2010; the stock trades on NYSE under the ticker TAK.
What do analysts say about Takeda Pharmaceutical Company stock?
6 analysts rate the stock, the consensus is Buy (as of 16/05/2023).
This is an external assessment, not a statement by Market Jury.
When does Takeda Pharmaceutical Company report next?
The next earnings date is 29/10/2026.
Around past earnings, price swings were roughly 2% stronger than usual.
Does Takeda Pharmaceutical Company pay a dividend?
Yes. The last dividend was US$0.40 per share.
The dividend yield is 3.2% (as of 30/06/2026).
Which stocks are comparable to Takeda Pharmaceutical Company?
Comparable stocks include Merck, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings, Amneal Pharmaceuticals and Indivior Pharmaceuticals.
How can I get Takeda Pharmaceutical Company stock analyzed?
Clicking "Analyze stock" lets five strategies assess Takeda Pharmaceutical Company against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.